BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16982358)

  • 21. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
    Bebarta VS; Ferre RM; Peck M
    J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.
    Bebarta V; Dart RC
    J Toxicol Clin Toxicol; 2004; 42(3):321-4. PubMed ID: 15362603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rattlesnake envenomation to the face of an infant.
    Richardson WH; Barry JD; Tong TC; Williams SR; Clark RF
    Pediatr Emerg Care; 2005 Mar; 21(3):173-6. PubMed ID: 15744196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized multicenter trial of Crotalidae polyvalent immune F(ab) antivenom for the treatment of rattlesnake envenomation in dogs.
    Peterson ME; Matz M; Seibold K; Plunkett S; Johnson S; Fitzgerald K
    J Vet Emerg Crit Care (San Antonio); 2011 Aug; 21(4):335-45. PubMed ID: 21827591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crotaline Fab antivenom reverses platelet dysfunction induced by Crotalus scutulatus venom: an in vitro study.
    Carstairs SD; Kreshak AA; Tanen DA
    Acad Emerg Med; 2013 May; 20(5):522-5. PubMed ID: 23672368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA; Mascarenas DN; Fullerton L; Warrick BJ; Smolinske SC
    Toxicon; 2020 Sep; 184():55-56. PubMed ID: 32505639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
    Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
    Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Images in clinical medicine. Rattlesnake envenomation.
    Levine M; Ruha AM
    N Engl J Med; 2010 Jun; 362(23):2212. PubMed ID: 20558372
    [No Abstract]   [Full Text] [Related]  

  • 29. Large snake size suggests increased snakebite severity in patients bitten by rattlesnakes in Southern california.
    Janes DN; Bush SP; Kolluru GR
    Wilderness Environ Med; 2010 Jun; 21(2):120-6. PubMed ID: 20591373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
    Offerman SR; Bush SP; Moynihan JA; Clark RF
    Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Crotalidae polyvalent antivenin for the treatment of hognosed viper (Porthidium nasutum) envenomation.
    Schier JG; Wiener SW; Touger M; Nelson LS; Hoffman RS
    Ann Emerg Med; 2003 Mar; 41(3):391-5. PubMed ID: 12605207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
    Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
    Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crotalidae polyvalent immune Fab antivenom limits the decrease in perfusion pressure of the anterior leg compartment in a porcine crotaline envenomation model.
    Tanen DA; Danish DC; Clark RF
    Ann Emerg Med; 2003 Mar; 41(3):384-90. PubMed ID: 12605206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
    Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catastrophic acute ischemic stroke after Crotalidae polyvalent immune Fab (ovine)-treated rattlesnake envenomation.
    Bush SP; Mooy GG; Phan TH
    Wilderness Environ Med; 2014 Jun; 25(2):198-203. PubMed ID: 24864067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children.
    Johnson PN; McGoodwin L; Banner W
    Emerg Med J; 2008 Dec; 25(12):793-8. PubMed ID: 19033492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom.
    Seifert SA; Boyer LV; Dart RC; Porter RS; Sjostrom L
    Ann Emerg Med; 1997 Jul; 30(1):49-53. PubMed ID: 9209225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of a southern Pacific rattlesnake (Crotalus viridis helleri) bite in a caracal (Caracal caracal).
    Singleton CL; Oosterhuis JE; Seibold K; Lamberski N
    J Zoo Wildl Med; 2009 Jun; 40(2):378-81. PubMed ID: 19569491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pygmy rattlesnake envenomation treated with Crotalidae Polyvalent Immune Fab Antivenom.
    King AM; Crim WS; Menke NB; Pizon AF
    Toxicon; 2012 Dec; 60(7):1287-9. PubMed ID: 22963729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.